Most moles are harmless, but certain visual changes and physical symptoms can signal skin cancer. The key is knowing what to look for and understanding that not all skin cancers look the same. Melanoma, the most dangerous type, has a nearly 100% five-year survival rate when caught early and confined to the skin, but that drops to 34% once it spreads to distant parts of the body. Spotting warning signs early makes an enormous difference.
The ABCDE Checklist
The most widely used framework for evaluating a suspicious mole checks five features:
- Asymmetry: One half of the mole doesn’t match the other in shape.
- Border: The edges are ragged, notched, or blurred rather than smooth. Pigment may spread into the surrounding skin.
- Color: Instead of a single uniform shade, you see a mix of brown, tan, and black, sometimes with patches of white, gray, red, pink, or blue.
- Diameter: Most melanomas are larger than 6 millimeters (roughly the size of a pencil eraser) at diagnosis, though they can be smaller.
- Evolving: The mole has changed in size, shape, or color over the past few weeks or months.
You don’t need all five features to be concerned. Even one, especially evolution, is enough to warrant a closer look.
Why Size Alone Isn’t Reliable
The 6mm diameter guideline is useful but imperfect. Studies show that anywhere from 2% to 38% of diagnosed melanomas are smaller than 6mm, depending on the study. One analysis of nearly 500 melanomas found that 16% were 6mm or under, and 5% were smaller than 4mm. Dermatologists are catching more of these small melanomas over time. In one Italian center, the proportion of melanomas under 6mm doubled from about 12% to 26% over a 14-year period. A tiny mole with irregular color or an evolving shape still deserves attention.
The Ugly Duckling Sign
Your moles tend to resemble each other. They share a general color palette, shape, and size that’s unique to your skin. The “ugly duckling” approach asks a different question than the ABCDE checklist: instead of analyzing a single mole in isolation, you compare it to the moles around it. The one that looks nothing like the others is the most suspicious for cancer.
This method catches melanomas that might not trigger the ABCDE criteria on their own. A mole could be relatively symmetrical and under 6mm but still stand out dramatically from every other spot on your body. The two approaches work best together, not as substitutes for each other.
Physical Symptoms That Matter
Visual changes aren’t the only warning. A mole that starts itching, bleeding, becoming crusty, or feeling sore or swollen is worth getting checked. These symptoms don’t guarantee cancer, as irritation from clothing or minor trauma can cause similar sensations. But a mole that bleeds without being scratched, or one that persistently itches when it never did before, is behaving abnormally.
How Fast Dangerous Moles Change
The speed of change matters. Aggressive melanomas have been reported to double in size in as little as 30 days, while slower-growing skin cancers like basal cell carcinoma develop over months to years. As a general rule, noticeable mole changes happening over weeks to months are a cause for concern. A mole that looked the same five years ago and looks the same today is far less worrying than one that appeared or changed shape in the last two months.
Skin Cancers That Don’t Look Like Moles
Not all skin cancer starts in a mole. Basal cell carcinoma, the most common type, often appears as a small pink or red translucent bump with a pearly or shiny surface, sometimes with visible blood vessels. It can also look like a flat, pale, scar-like area or an open sore that won’t heal. Squamous cell carcinoma tends to show up as rough, scaly red patches that may crust or bleed, raised lumps, or wart-like growths.
Both types share one hallmark: a sore that doesn’t heal, or heals and comes back. If you have a spot that has been open, oozing, or crusted for weeks without resolving, that pattern is more telling than what the spot looks like on any given day. On darker skin tones, these cancers may appear as darker patches rather than pink or red, which can make them harder to spot.
Who Needs to Be Extra Vigilant
Everyone should keep an eye on their skin, but some people carry higher risk. Having 10 or more atypical moles (larger, irregularly shaped moles that aren’t quite normal but aren’t cancer) makes you 12 times more likely to develop melanoma. Other factors that raise your risk include fair skin that burns easily, a history of blistering sunburns, a family history of melanoma, and a personal history of any skin cancer.
If you fall into a higher-risk category, regular full-body skin checks become more important. Many dermatologists recommend annual professional exams for high-risk patients, with monthly self-checks at home using a mirror for hard-to-see areas like your back and scalp.
What Happens When You Get a Mole Checked
A dermatologist’s first tool is a dermatoscope, a handheld magnifying device with its own light source that reveals structures beneath the skin’s surface invisible to the naked eye. This significantly improves accuracy. When dermatoscopy is combined with a visual exam, sensitivity for detecting melanoma jumps to about 92% compared to 76% for visual inspection alone at the same level of specificity. It also helps avoid unnecessary biopsies by better identifying harmless moles.
If a spot looks suspicious under dermatoscopy, the next step is a biopsy, where a small sample of tissue is removed and examined under a microscope. For suspected basal or squamous cell carcinoma, dermatologists typically use a shave biopsy (removing a thin layer from the surface) or a punch biopsy (a small circular tool that reaches deeper). For suspected melanoma, an excisional biopsy is preferred, removing the entire suspicious area to ensure nothing is missed. All three procedures are done with local anesthesia in a clinic visit and typically take under 30 minutes.
Results usually come back within one to two weeks. If the biopsy confirms cancer, the type and depth of the growth determine what treatment looks like, from a simple outpatient procedure for early-stage cases to more involved treatment plans for deeper or spreading cancers.